Caribou Biosciences, Inc. Share Price
CRBUCaribou Biosciences, Inc. Stock Performance
Open $1.59 | Prev. Close $1.50 | Circuit Range N/A |
Day Range $1.46 - $1.65 | Year Range $0.66 - $3.54 | Volume 41,120 |
Average Traded $1.53 |
Caribou Biosciences, Inc. Share Price Chart
About Caribou Biosciences, Inc.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis, and extrarenal lupus. It also develops CB-011, an anti-BCMA allogeneic CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Caribou Biosciences, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Feb-26 | $1.57 | $1.63 | +4.15% |
03-Feb-26 | $1.55 | $1.56 | +7.19% |
02-Feb-26 | $1.40 | $1.46 | +4.29% |
30-Jan-26 | $1.46 | $1.40 | -5.08% |
29-Jan-26 | $1.50 | $1.48 | -2.96% |
28-Jan-26 | $1.54 | $1.52 | -2.25% |
27-Jan-26 | $1.58 | $1.55 | +1.63% |
FAQs on Caribou Biosciences, Inc. Share Price
Can I buy Caribou Biosciences, Inc. shares in India?
What is the share price of Caribou Biosciences, Inc.?
What is the 5 year returns of Caribou Biosciences, Inc.?
What are the high & low stock price of Caribou Biosciences, Inc. today?
What is the 52-week high and low of Caribou Biosciences, Inc. stock?